Intrinsic value of Artiva Biotherapeutics, Inc. (ARTV)
Live fair value data for Artiva Biotherapeutics, Inc. (ARTV) is currently unavailable. Please check again shortly.
Current Price: $267.00
Valuation: Overvalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Artiva Biotherapeutics, Inc. (ARTV) undervalued or overvalued?
Based on the current model output, Artiva Biotherapeutics, Inc. appears to be overvalued with a downside of 10.00%.
Fair value vs market price — Artiva Biotherapeutics, Inc. (ARTV)
Unlock premium access to view the live fair value comparison against current market price for ARTV.
Frequently Asked Questions - ARTV
How is ARTV intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ARTV.
Is ARTV undervalued or overvalued right now?
ARTV is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ARTV: open their intrinsic value pages.